2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline has been researched along with fenbendazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asamoto, M; Hirose, M; Inaguma, S; Ogiso, T; Shirai, T; Suzuki, S; Takahashi, S | 1 |
1 other study(ies) available for 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline and fenbendazole
Article | Year |
---|---|
Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole--a CYP1A2 inducer.
Topics: Animals; Antinematodal Agents; Arylamine N-Acetyltransferase; Blotting, Western; Carcinogens; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A2; DNA Primers; Drug Combinations; Drug Synergism; Enzyme Induction; Fenbendazole; Glutathione Transferase; Immunoenzyme Techniques; Liver; Liver Neoplasms, Experimental; Male; Microsomes, Liver; Quinoxalines; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction | 2002 |